Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Nov;70(5):1866-1868.
doi: 10.1002/hep.30812. Epub 2019 Aug 12.

Phenotype or Genotype: Decision-Making Dilemmas in Hepatocellular Adenoma

Affiliations
Case Reports

Phenotype or Genotype: Decision-Making Dilemmas in Hepatocellular Adenoma

Anne J Klompenhouwer et al. Hepatology. 2019 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Macroscopic and microscopic images, Case 1: (A) macroscopy of one of the small whitish nodules in the hemorrhagic background of the HCA, (B) microscopy of hematoxylin and eosin staining, (C) microscopy of reticulin staining denoting the disorganized reticulin with forming of broad liver plates, (D) immunohistochemistry of CRP with dense reinforcement of expression at the periphery, (E) immunohistochemistry of diffuse positive glypican‐3 staining.
Figure 2
Figure 2
Macroscopic and microscopic images, Case 2: (A) macroscopic and microscopic images of the small lesion, (A‐I) macroscopy, (A‐II) microscopy of hematoxylin and eosin (H‐E) staining, (A‐III) immunohistochemistry of CRP with diffuse positive staining, (A‐IV) immunohistochemistry of GS with diffuse positive staining; (B) macroscopic and microscopic images of the large lesion, (B‐I) macroscopy, (B‐II) microscopy of H‐E staining, (B‐III) immunohistochemistry of CRP with diffuse positive staining, and (B‐IV) immunohistochemistry of GS with perivascular staining, no diffuse pattern.

Similar articles

Cited by

  • New insights in the management of Hepatocellular Adenoma.
    Klompenhouwer AJ, de Man RA, Dioguardi Burgio M, Vilgrain V, Zucman-Rossi J, Ijzermans JNM. Klompenhouwer AJ, et al. Liver Int. 2020 Jul;40(7):1529-1537. doi: 10.1111/liv.14547. Epub 2020 Jun 11. Liver Int. 2020. PMID: 32464711 Free PMC article. Review.
  • Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course.
    van Rosmalen BV, Furumaya A, Klompenhouwer AJ, Tushuizen ME, Braat AE, Reinten RJ, Ligthart MAP, Haring MPD, de Meijer VE, van Voorthuizen T, Takkenberg RB, Dejong CHC, de Man RA, IJzermans JNM, Doukas M, van Gulik TM, Verheij J; Dutch Benign Liver Tumor Group and the PALGA group. van Rosmalen BV, et al. Liver Int. 2021 Oct;41(10):2474-2484. doi: 10.1111/liv.14989. Epub 2021 Jul 8. Liver Int. 2021. PMID: 34155783 Free PMC article.

References

    1. Nault JC, Bioulac‐Sage P, Zucman‐Rossi J. Hepatocellular benign tumors‐from molecular classification to personalized clinical care. Gastroenterology 2013;144:888‐902. - PubMed
    1. Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 2017;152:880‐894.e6. - PubMed
    1. Bioulac‐Sage P, Sempoux C, Possenti L, Frulio N, Laumonier H, Laurent C, et al. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol 2013;2013:253261. - PMC - PubMed
    1. Rebouissou S, Franconi A, Calderaro J, Letouzé E, Imbeaud S, Pilati C, et al. Genotype‐phenotype correlation of CTNNB1 mutations reveals different β‐catenin activity associated with liver tumor progression. Hepatology 2016;64:2047‐2061. - PubMed
    1. European Association for the Study of the Liver . EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol 2016;65:386‐398. - PubMed

Publication types